| 000 | 01634 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515225041.0 | ||
| 264 | 0 | _c20101116 | |
| 008 | 201011s 0 0 eng d | ||
| 022 | _a1880-3873 | ||
| 024 | 7 |
_a10.5551/jat.3293 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGeraldo, R B | |
| 245 | 0 | 0 |
_aAntiplatelet activity and structure-activity relationship study of Pyrazolopyridine Derivatives as potential series for treating thrombotic diseases. _h[electronic resource] |
| 260 |
_bJournal of atherosclerosis and thrombosis _cJul 2010 |
||
| 300 |
_a730-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aPyrazoles _xchemical synthesis |
| 650 | 0 | 4 |
_aPyridines _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 700 | 1 | _aBello, M L | |
| 700 | 1 | _aDias, L R S | |
| 700 | 1 | _aVera, M A F | |
| 700 | 1 | _aNagashima, T | |
| 700 | 1 | _aAbreu, P A | |
| 700 | 1 | _aSantos, M B | |
| 700 | 1 | _aAlbuquerque, M G | |
| 700 | 1 | _aCabral, L M | |
| 700 | 1 | _aFreitas, A C C | |
| 700 | 1 | _aKalil, M V | |
| 700 | 1 | _aRodrigues, C R | |
| 700 | 1 | _aCastro, H C | |
| 773 | 0 |
_tJournal of atherosclerosis and thrombosis _gvol. 17 _gno. 7 _gp. 730-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5551/jat.3293 _zAvailable from publisher's website |
| 999 |
_c19873659 _d19873659 |
||